[Methodology of new pharmacoeconomic method "impact on hospital budget" by the example of local hemostatic agents in abdominal surgery].
Krysanov
I S
IS
Kulikov
A Iu
AIu
D034841:Abdominal Cavity / Q000601:surgery; D007611:Aprotinin / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D017850:Economics, Pharmaceutical; D005340:Fibrinogen / Q000191:economics* / Q000627:therapeutic use; D005377:Financial Management, Hospital; D006296:Health Services / Q000191:economics*; D006488:Hemostasis, Surgical / Q000191:economics; D006490:Hemostatics / Q000191:economics* / Q000627:therapeutic use; D017721:Hospital Costs; D006801:Humans; D012426:Russia; D013514:Surgical Procedures, Operative / Q000191:economics*; D013917:Thrombin / Q000191:economics* / Q000627:therapeutic use
D004338:Drug Combinations; D006490:Hemostatics; C093991:tachocomb; D005340:Fibrinogen; D007611:Aprotinin; D013917:Thrombin